Navigating a Rapidly Evolving Treatment Landscape for Relapsed/Refractory Myeloma: Integrating the Latest Data to Transform Care

Download these slides from a live expert-led webinar reviewing the latest advances in Relapsed/Refractory Myeloma.
Rebecca Gonzalez, PharmD, BCOP
Donald C. Moore, PharmD, BCPS, BCOP, DPLA
Format: Microsoft PowerPoint (.ppt)
File Size: 3.43 MB
Released: July 7, 2022

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Karyopharm Therapeutics Inc.

Related Content

Pharmacists review the latest findings in the treatment of relapsed/refractory multiple myeloma and provide clinical insights based on their personal experiences, from Clinical Care Options (CCO).

Rebecca Gonzalez, PharmD, BCOP Donald C. Moore, PharmD, BCPS, BCOP, DPLA Released: July 29, 2022

On-demand webcast from ProCE and Clinical Care Options (CCO), Rebecca Gonzalez, PharmD, BCOP, and Bhavesh Shah, RPh, BCOP, discuss the management of relapsed/refractory multiple myeloma

Rebecca Gonzalez, PharmD, BCOP Bhavesh Shah, RPh, BCOP Pharmacists: 1.5 contact hours (0.15 CEUs) Released: June 15, 2022 Expired: June 14, 2023

Rebecca Gonzalez, PharmD, BCOP, discusses key pharmacy strategies for management of patients with multiple myeloma in this commentary from Clinical Care Options (CCO)

Rebecca Gonzalez, PharmD, BCOP Released: May 6, 2022

On-demand webcast on CAR T-cells for patients with hematologic malignancies, from Clinical Care Options (CCO)

Craig Freyer, PharmD, BCOP Andrew Lin, PharmD, BCOP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 28, 2022 Expired: April 27, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings